They don't need to start a new trial Despite targeting 5 antigens they observed that the MultiTAA tech was recruiting other parts of the immune system that were dorman targeting other antigens on the surface of tumor cells with epitope spreading. It's something that always happens and was observed in several studies already.
News 
Market Data 
Discover 
AI
